Integra LifeSciences Corporation Announces Launch of the Integra(R) IPP-ON(R) PIP Fusion System for Extremity Reconstruction

Published: Jun 20, 2012

PLAINSBORO, N.J., June 20, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the introduction of Integra® IPP-ON® PIP Fusion System, for fixation of proximal interphalangeal (PIP) joint arthrodesis. It is indicated for use in the lesser toes for rigid or semi-rigid hammertoe deformity, revision of failed arthroplasty or arthrodesis, and second toe shortening. The Integra® IPP-ON® PIP Fusion System has received 510(k) clearance from the United States Food & Drug Administration (FDA), and will be featured at the American Orthopaedic Foot & Ankle Society 2012 Annual Meeting on June 20-23, 2012 in San Diego, California.

Back to news